Group | n | Gender (n) | Age ( , Years) | Number of Ulcers ( , Persons) | Interval of Ulcers ( , Days) | |
Male | Female | |||||
Positive Control Group (Thalidomide) | 12 | 6 | 6 | 49.50 ± 22.70 | 26.50 ± 11.19 | 85.5 ± 15.59 |
Trial Group (Yiqing Capsules) | 38 | 20 | 18 | 46.16 ± 16.21 | 20.58 ± 12.20 | 82.89 ± 40.55 |
Negative Control Group (Local Medication) | 24 | 16 | 8 | 46.00 ± 19.22 | 17.83 ± 10.02 | 85 ± 44.31 |
χ2/F | - | 1.447 | 0.174 | 2.321 | 0.032 | |
P | - | 0.538 | 0.841 | 0.106 | 0.969 |